Guardant Health Company Top Insiders

Guardant Health's latest congressional trading

Guardant Health Management Team Effectiveness

The company has Return on Asset (ROA) of (0.1964) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1964. This is way below average. Likewise, it shows a return on total equity (ROE) of (45.8447) %, which implies that it produced no returns to current stockholders. Guardant Health's management efficiency ratios could be used to measure how well Guardant Health manages its routine affairs as well as how well it operates its assets and liabilities. The Guardant Health's current Return On Equity is estimated to increase to 4.40, while Return On Tangible Assets are projected to decrease to (0.23). As of now, Guardant Health's Debt To Assets are increasing as compared to previous years. The Guardant Health's current Asset Turnover is estimated to increase to 0.51, while Total Assets are projected to decrease to under 1.5 B. The current Common Stock Shares Outstanding is estimated to decrease to about 101.3 M. The Guardant Health's current Net Loss is estimated to increase to about (559.7 M)The majority of Guardant Health outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Guardant Health to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Guardant Health. Please pay attention to any change in the institutional holdings of Guardant Health as this could imply that something significant has changed or is about to change at the company. On December 1, 2025, Senator Sheldon Whitehouse of US Senate acquired under $15k worth of Guardant Health's common stock. Some institutional investors establish a significant position in stocks such as Guardant Health in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Guardant Health, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Guardant Health Workforce Comparison

Guardant Health Profit Margins

The company has Net Profit Margin (PM) of (0.44) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.37) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.37.

Guardant Health Insider Trading History

Guardant Health Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Guardant Health often depends on how effective the management is. Guardant Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Guardant management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Guardant management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.